|Articles|November 21, 2022
Quality Control Analysis of Oligonucleotide Therapeutics: One Platform Method for Determining Identity, Purity, and Quantity
Author(s)Waters
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
4
Behind the Headlines Episode 29: 2025 Year in Review
5
